PISKEL KYLE

Chief Financial Officer

PISKEL KYLE has filed 7 SEC Form 4 filings (12 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: May 20, 2026.

On the most recent filing, PISKEL KYLE is listed as Chief Financial Officer at Adaptive Biotechnologies Corp. Inside the rolling window, PISKEL KYLE reported no open-market purchases and 6 open-market sales totaling $3.6M in ADPT. The largest disclosed transaction in the window is a sale of 162,820 ADPT shares on Nov 28, 2025, worth $3.2M.

Companies traded

Other insiders at ADPT

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$3.6M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ADPTSale$41KMay 20SEC ↗
ADPTSale$246KMar 13SEC ↗
ADPTSale$40KFeb 6SEC ↗
ADPTSale$77KJan 14SEC ↗
ADPTSale$3.2MDec 2SEC ↗
ADPTSale$3KNov 18SEC ↗
Showing 1–6 of 6
1 / 1

Frequently asked questions

How many SEC Form 4 filings has PISKEL KYLE made?

PISKEL KYLE has filed 7 SEC Form 4 filings (12 transaction rows) across 1 company since 2025.

Which companies does PISKEL KYLE trade?

PISKEL KYLE has filed SEC Form 4 disclosures for 1 company, including ADPT.

When was PISKEL KYLE's most recent SEC Form 4 filing?

PISKEL KYLE's most recent SEC Form 4 filing on Tracefour is dated May 20, 2026.

What is PISKEL KYLE's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, PISKEL KYLE is listed as Chief Financial Officer.

What is PISKEL KYLE's total buy and sell value in the current window?

Inside the rolling retention window, PISKEL KYLE bought $0 and sold $3.6M based on SEC Form 4 filings.

What was PISKEL KYLE's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 162,820 ADPT shares on 2025-11-28, worth $3.2M, per SEC Form 4 filings.